Financial Disclosure Statement

Daojing Wang
Newomics Inc.

MSACL 2015 US Abstract Title:
Clinical Applications of Top-down Proteomics

DescriptionY/NSource
Grantsno
SalaryyesNewomics Inc.
Board MemberyesNewomics Inc.
Stockyes Newomics Inc.
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

yes